Valuation
- Market cap
- 18,946,000
- Revenue TTM
- $10,250,000
- Net income TTM
- $-5,350,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- -52.20%
- Debt to equity
- 0.00
Trading
- Volume
- 47,100
- Avg volume
- 113,812
- Day's range
- $10.98 – $11.00
- Shares out
- 1,722,000
- Stochastic %K
- 100%
- Beta
- -0.15
- Analysts
- Hold
- Price target
- $10.00
Company profile
Evoke Pharma, Inc. operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, pri...
Show more
Evoke Pharma, Inc. operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is based in Solana Beach, California. As of December 15, 2025, Evoke Pharma, Inc. operates as a subsidiary of QOL Medical, LLC.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- Phone
- 858 345 1494
- Website
- https://www.evokepharma.com
- Address
- 420 Stevens Avenue, Suite 230, Solana Beach, United States
Latest news
No headlines yet.
